Abstract Details
|
David Lin, MD
(Massachusetts General Hospital)
PRESENTER |
Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurotrauma Sciences. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IoTA Biosciences. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encompass Health. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Best in Class MD. |
| Seth N. Levin, MD (Biogen) | Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen. |
| Anoopum Gupta, MD, PhD (Massachusetts General Hospital, Brigham, Harvard) | Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen. |
| Sebastian Urday, MD (Northwestern Medicine) | Dr. Urday has nothing to disclose. |
| No disclosure on file | |
| Nagagopal Venna, MBBS, FAAN (Massachusetts General Hospital) | Dr. Venna has nothing to disclose. |